MetaCap

Rapport Therapeutics Statistics

NASDAQ: RAPPHealth CareBiotechnology: Pharmaceutical PreparationsUSD

23.16-0.43 (-1.82%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Rapport Therapeutics by the numbers

Rapport Therapeutics has a market capitalization of $1.37 billion based on 59.28M shares outstanding. With trailing EPS of $-3.17, Rapport Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 22.4% below its 50-day average and 34.8% below its 200-day average.

Average daily trading volume is 790.62K shares, or about $18.3 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

RAPP valuation vs. peer median

RAPP compared with the median of 8 peer companies
MetricRAPPPeer medianDifference
Market cap$1.37B$1.41B-3%
Avg. volume790.62K965.94K-18%

Peer median across 8 companies: NRIX, TYRA, ANAB, ADRX, SRPT, KLRA, DMRA, QURE.

Valuation

Price and trading

Previous close
23.59
Open
23.23
Day range
23.00 – 23.83
52-week range
22.06 – 52.93
52-week change
-15.01%
Beta
—
Volume
437.72K

Dividends and events

Annual dividend
None

Additional statistics

Market Cap
1.37B
Forward Pe
-5.84
Eps
-3.17
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
52.93
Week52 Low
22.06
Avg Volume
790.62K
Shares Outstanding
59.28M
Ma50
29.85
Ma200
35.51
Earnings Date
Nov 4, 2026
Pct From52w High
-56.24%
Pct From52w Low
4.98%

Related